Adaptive Biotechnologies Corporation
US ˙ NasdaqGS ˙ US00650F1093

SecurityADPT / Adaptive Biotechnologies Corporation
InstitutionCreative Planning
Latest Disclosed Ownership83,443 shares
Latest Disclosed Value $ 1,158,189
Creative Planning reports 1.66% decrease in ownership of ADPT / Adaptive Biotechnologies Corporation

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 83,443 shares of Adaptive Biotechnologies Corporation (US:ADPT) valued at $1,158,189 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 84,853 shares of Adaptive Biotechnologies Corporation. This represents a change in shares of -1.66% during the quarter. The current value of the position is $1,334,254 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 83,443 -1,410 -1.66 1,158 -15.97 0.0008
2026-02-17 2025-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 84,853 6,242 7.94 1,378 17.18 0.0010
2025-11-14 2025-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 78,611 5,007 6.80 1,176 37.22 0.0009
2025-08-08 2025-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 73,604 27,532 59.76 857 150.58 0.0007
2025-05-15 2025-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 46,072 -5,486 -10.64 342 10.68 0.0003
2025-02-14 2024-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 51,558 2,234 4.53 309 22.62 0.0003
2024-10-11 2024-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 49,324 1,918 4.05 253 47.37 0.0003
2024-08-15 2024-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 47,406 24,952 111.12 172 137.50 0.0002
2024-05-13 2024-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 22,454 2,142 10.55 72 -27.27 0.0001
2024-02-14 2023-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 20,312 190 0.94 100 -9.17 0.0002
2023-11-16 2023-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 20,122 -8,407 -29.47 110 -42.93 0.0001
2023-07-21 2023-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 28,529 7,297 34.37 191 2.14 0.0003
2023-05-15 2023-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 21,232 106 0.50 187 16.15 0.0003
2023-02-10 2022-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 21,126 1,887 9.81 161 17.52 0.0002
2022-11-03 2022-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 19,239 94 0.49 137 -11.61 0.0002
2022-08-15 2022-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 19,145 -130 -0.67 155 -42.16 0.0003
2022-05-16 2022-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 19,275 131 0.68 268 -50.09 0.0004
2022-02-11 2021-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 19,144 -236 -1.22 537 -18.51 0.0009
2021-11-10 2021-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 19,380 0 0.00 659 -16.79 0.0012
2021-08-04 2021-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 19,380 -1,307 -6.32 792 -4.92 0.0014
2021-04-30 2021-03-31 13F CreativePlanning COM 00650F109 20,687 -2,523 -10.87 833 -39.29 0.0017
2021-01-29 2020-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 23,210 -8,897 -27.71 1,372 -12.11 0.0030
2020-11-05 2020-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 32,107 657 2.09 1,561 2.56 0.0041
2020-07-23 2020-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 31,450 200 0.64 1,522 75.35 0.0044
2020-05-05 2020-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 31,250 31,250 868 0.0031
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.